Research from University of Pennsylvania School of Veterinary Medicine and Children’s Hospital of Philadelphia suggests that repurposing a cholesterol drug may benefit 22qDS patients with neuropsychiatric disease
Efficient delivery of synthetic mRNA to the retina remains one of the key hurdles in developing mRNA-based treatments for vision loss.
A new study recently underway at the University of Pennsylvania School of Veterinary Medicine’s (Penn Vet) New Bolton Center, led by Associate Professor of Epidemiology Laurel Redding, aims to shed…
Retinal blindness caused by the death of photoreceptors, the light-sensing cells within the retina, affects millions of people worldwide. Novel gene and cell therapies to prevent or rescue vision loss…
Researchers identify metabolic stress as an obstacle to photoreceptor transplantation highlighting a critical window for therapeutic intervention.
A pioneering new study published in Nature Microbiology, led by Oriol Sunyer, PhD, and a team of researchers at Penn Vet and the University of New Mexico, have uncovered a…
A strain of the H5N1 virus—best known for causing avian influenza—was detected in U.S. dairy cattle for the first time in March 2024. It has since spread to more than…
Researchers at Penn Vet examine how common food waste recycling methods, including composting, could have a big impact on greenhouse gas emissions and the use of natural resources.
Researchers at the University of Pennsylvania’s School of Veterinary Medicine (Penn Vet), in collaboration with the Pennsylvania Game Commission, are studying the complex interactions between ticks, pathogens, hosts, and their…
Penn Vet and Penn Medicine researchers have modified mRNA vaccines to include the cytokine IL-12 and improve T-cell responses which could improve the body’s ability to fight infections.
